StemCell Institute (7096.T) Stock Price
StemCell Institute Price
Revenue has compounded at 15.9% per year over the past 8 years to 2.81 B JPY. Earnings per share have grown at 10.9% per year over the last 8 years. StemCell Institute's net margin stands at 5.5%, down from 7.5% several years earlier. StemCell Institute currently offers a dividend yield of about 3.34%. The payout ratio is around 82% of earnings.
StemCell Institute stock price
StemCell Institute business model & stock analysis
Frequently asked questions about StemCell Institute
5 analysts currently rate the StemCell Institute stock: 4 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the StemCell Institute share trades at 4.23 EUR (748.00 JPY).
The revenue of StemCell Institute is 2.81 B JPY. This figure is based on current financial data and reflects the company's business performance.
The profit of StemCell Institute is 155.92 M JPY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of StemCell Institute is currently 48.31. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the StemCell Institute stock.
The price-to-sales ratio (P/S) of StemCell Institute is currently 2.68. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the StemCell Institute stock.
The Eulerpool Quality Score for StemCell Institute is 3/10.
The ISIN of StemCell Institute is JP3399640006. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of StemCell Institute is 7096.T. The ticker symbol is used to trade StemCell Institute shares on the stock exchange.
StemCell Institute stock
StemCell Institute Peer Group
StemCell Institute FIGI
All fundamentals and in-depth analysis of StemCell Institute
Our stock analysis for StemCell Institute stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of StemCell Institute. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.